FDAnews
www.fdanews.com/articles/177945-spectranetics-earns-ce-mark-for-angiosculptx-drug-coated-catheter

Spectranetics Earns CE Mark for AngioSculptX Drug-coated Catheter

August 11, 2016

Spectranetics has attained CE Mark approval in the EU for its AngioSculptX drug-coated balloon catheter designed to treat coronary artery stenosis.

The device also was granted indications for the treatment of hemodynamically significant coronary artery stenosis, including in-stent restinosis, the company said.

It is meant to be used in percutaneous transluminal coronary angioplasty procedures. — Cynthia Jessup

View today's stories